Revitalist Enters Joint-Venture Partnership with GCM Partners, LLC, Expanding Access to an Additional 50,000 Patients

VANCOUVER, BC, April 11, 2023 — REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4D0O) announces an exciting joint-venture partnership where Revitalist will gain access to five new locations in Chicago, IL (2), Orlando, FL (2), and Miami, FL. These centrally located offices will now be able to serve […]

Revitalist Enters into Network Agreement for Specialty Providers with Corechoice

(CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CoreChoice has entered into an agreement with Revitalist to participate in their Behavioral Health Network. This relationship will allow Revitalist to access many more patients to extend care for Behavioral Health. Furthermore, Revitalist is also pleased in announce a new COO Paul Auchterlonie. Paul Auchterlonie brings three decades of […]

Revitalist Announces Closing of Private Placement

VANCOUVER, British Columbia–(BUSINESS WIRE)–REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), announces the closing of a non-brokered private placement. This funding will allow Revitalist to start extending its proprietary telemedicine platform across 28 states, with the goal of giving access to more than 50M individuals living with mental […]

Bullish Start to the Year for Psychedelic Drug Development Companies Ahead of a Plethora of Potential Positive Events

Managements in the neuropharmaceutical psychedelics space are upbeat ahead of near-term catalysts. Earlier this month, we met with most of the managements in our coverage universe of companies pursuing psychoactive agents for various mood disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD), among others. Collectively, the teams expressed optimism regarding their lead compounds […]

Revitalist’s Kathryn Walker and Awakn’s Prof. David Nutt to host webinar on ketamine-assisted therapy for Veterans’ suffering with Addictions

Revitalist to launch first treatments for those suffering from Alcohol Use Disorder with Awakn’s revolutionary Kare treatment VANCOUVER, BC, December 19, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), is partnering with Awakn’s Prof. David Nutt to discuss ketamine-assisted therapy for Veterans suffering with Addictions in […]

Revitalist and Wake Network Announce Joint Venture Partnership to Open Psychedelic Clinics and Retreats in the United States

VANCOUVER, BC, November 14, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE:4DO), Revitalist and WAKE Network, Inc. announce the joint venture partnership opening psychedelic clinics and retreats with vertical offerings with a personalized medicine and therapy approach. Revitalist continues to establish its presence as a first full-service […]

Revitalist CEO Awarded Professional Service Practitioner of the Year by Microdose

VANCOUVER, BC, November 7, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), CEO Kathryn Walker awarded Microdose’s “Professional Service Practitioner of the Year”, following last year’s win of  “Entrepreneur of the Year” in 2021 at Wonderland: Miami, the largest psychedelic medicine business event. “I am honored […]

Revitalist Releases Supplement Line to Enhance the Results of Psychedelic Medicines

VANCOUVER, BC, November 2, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), releases proprietary supplement lines to extend the results of psychedelic medicine outcomes. Through a proprietary blend of vitamins, anti-inflammatories and known cognitive enhancing ingredients, Revive+ and Restore+ have been formulated to enhance psychedelic therapy. […]

Revitalist Increases Patient Access Making Care More Affordable by Financing the Cost with M-Lend Financial

VANCOUVER, BC, November 1, 2022 – REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), partners with patient financing company allowing client lending up to $100,000 USD per patient covering all Revitalist services including those related to ketamine and psychedelic medicine. Revitalist partners with M-Lend Financial allowing clients to […]

Revitalist Company Update Regarding Financial and Share Settlements

VANCOUVER, British Columbia, October 07, 2022-REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), Revitalist takes protagonist approach improving financial and share positioning for forward moving growth strategies. Revitalist continues to take advancements to improve company operations, financial standings, and overall share delineation to improve company outlooks and infrastructure. […]